Cargando…

Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China

BACKGROUND: The all-cause mortality of patients undergoing hemodialysis (HD) is higher than in the general population. The first 6 months after dialysis are important for new patients. The aim of this study was to develop and validate a nomogram for predicting the 6-month survival rate of HD patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guode, Jiang, linsen, Li, Jiangpeng, Shen, Huaying, Jiang, Shan, Ouyang, Han, Song, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248113/
https://www.ncbi.nlm.nih.gov/pubmed/35778681
http://dx.doi.org/10.1186/s12882-022-02864-x
_version_ 1784739303966900224
author Li, Guode
Jiang, linsen
Li, Jiangpeng
Shen, Huaying
Jiang, Shan
Ouyang, Han
Song, Kai
author_facet Li, Guode
Jiang, linsen
Li, Jiangpeng
Shen, Huaying
Jiang, Shan
Ouyang, Han
Song, Kai
author_sort Li, Guode
collection PubMed
description BACKGROUND: The all-cause mortality of patients undergoing hemodialysis (HD) is higher than in the general population. The first 6 months after dialysis are important for new patients. The aim of this study was to develop and validate a nomogram for predicting the 6-month survival rate of HD patients. METHODS: A prediction model was constructed using a training cohort of 679 HD patients. Multivariate Cox regression analyses were performed to identify predictive factors. The identified factors were used to establish a nomogram. The performance of the nomogram was assessed using the C-index and calibration plots. The nomogram was validated by performing discrimination and calibration tests on an additional cohort of 173 HD patients. RESULTS: During a follow-up period of six months, 47 and 16 deaths occurred in the training cohort and validation cohort, respectively, representing a mortality rate of 7.3% and 9.2%, respectively. The nomogram comprised five commonly available predictors: age, temporary dialysis catheter, intradialytic hypotension, use of ACEi or ARB, and use of loop diuretics. The nomogram showed good discrimination in the training cohort [C-index 0.775(0.693–0.857)] and validation cohort [C-index 0.758(0.677–0.836)], as well as good calibration, indicating that the performance of the nomogram was good. The total score point was then divided into two risk classifications: low risk (0–90 points) and high risk (≥ 91 points). Further analysis showed that all-cause mortality was significantly different between the high-risk group and the low-risk group. CONCLUSIONS: The constructed nomogram accurately predicted the 6-month survival rate of HD patients, and thus it can be used in clinical decision-making.
format Online
Article
Text
id pubmed-9248113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92481132022-07-02 Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China Li, Guode Jiang, linsen Li, Jiangpeng Shen, Huaying Jiang, Shan Ouyang, Han Song, Kai BMC Nephrol Research BACKGROUND: The all-cause mortality of patients undergoing hemodialysis (HD) is higher than in the general population. The first 6 months after dialysis are important for new patients. The aim of this study was to develop and validate a nomogram for predicting the 6-month survival rate of HD patients. METHODS: A prediction model was constructed using a training cohort of 679 HD patients. Multivariate Cox regression analyses were performed to identify predictive factors. The identified factors were used to establish a nomogram. The performance of the nomogram was assessed using the C-index and calibration plots. The nomogram was validated by performing discrimination and calibration tests on an additional cohort of 173 HD patients. RESULTS: During a follow-up period of six months, 47 and 16 deaths occurred in the training cohort and validation cohort, respectively, representing a mortality rate of 7.3% and 9.2%, respectively. The nomogram comprised five commonly available predictors: age, temporary dialysis catheter, intradialytic hypotension, use of ACEi or ARB, and use of loop diuretics. The nomogram showed good discrimination in the training cohort [C-index 0.775(0.693–0.857)] and validation cohort [C-index 0.758(0.677–0.836)], as well as good calibration, indicating that the performance of the nomogram was good. The total score point was then divided into two risk classifications: low risk (0–90 points) and high risk (≥ 91 points). Further analysis showed that all-cause mortality was significantly different between the high-risk group and the low-risk group. CONCLUSIONS: The constructed nomogram accurately predicted the 6-month survival rate of HD patients, and thus it can be used in clinical decision-making. BioMed Central 2022-07-01 /pmc/articles/PMC9248113/ /pubmed/35778681 http://dx.doi.org/10.1186/s12882-022-02864-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Guode
Jiang, linsen
Li, Jiangpeng
Shen, Huaying
Jiang, Shan
Ouyang, Han
Song, Kai
Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China
title Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China
title_full Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China
title_fullStr Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China
title_full_unstemmed Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China
title_short Development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in China
title_sort development and validation of a nomogram for predicting the 6-months survival rate of patients undergoing incident hemodialysis in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248113/
https://www.ncbi.nlm.nih.gov/pubmed/35778681
http://dx.doi.org/10.1186/s12882-022-02864-x
work_keys_str_mv AT liguode developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina
AT jianglinsen developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina
AT lijiangpeng developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina
AT shenhuaying developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina
AT jiangshan developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina
AT ouyanghan developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina
AT songkai developmentandvalidationofanomogramforpredictingthe6monthssurvivalrateofpatientsundergoingincidenthemodialysisinchina